Medindia neither buys nor sells drugs. voriconazole (Voriva 200 mg) is an azole antifungal agent, prescribed for various fungal infections. It works by slowing the growth of the fungi that cause ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to ...

According to IMS MAT March 2016 sales data, Vfend tablets, 50 mg and 200 mg, had sales of $92.8 million while Vfend Oral Suspension, 40 mg/mL, had US sales of $15.9 million. Citing IMS data ...

Lupin and its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) have received final approvals for its voriconazole tablets, 50 mg & 200 mg and voriconazole oral suspension, 40 mg/ml from ...

“If we improve drug exposure, then we should be able ... Poor, intermediate and normal CYP2C19 metabolizers received voriconazole 200 mg twice daily, whereas rapid and ultrarapid CYP2C19 ...

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated May 25, 2016 titled "Zydus receives final approval from the USFDA for Voriconazole Tablets".Source : BSE Advisory Alert ...

Oral voriconazole was administered under fasting conditions at a maintenance dose of 200 mg per body every 12 ... with that just before initiating the drug. The Wilcoxon signed-rank test ...

Teva announced the launch of Voriconazole tablets, the generic version of Pfizer‘s Vfend tablets. Vfend is an azole anti-fungal indicated for fungal infections, particularly invasive ...

A total of 837 patients (415 assigned to voriconazole and 422 ... continued at a maintenance dose of 3 mg per kilogram intravenously every 12 hours (or 200 mg orally every 12 hours, after at ...

Voriconazole-treated patients had significantly fewer severe drug-related adverse events ... day (including lipid derivatives) or more than 200 mg of itraconazole per day during the preceding ...

including Fusarium solani in patients intolerant of or refractory to other therapy Vfend Tablets, 50 mg and 200 mg had US sales of $92.8 million (IMS MAT March 2016) while Vfend Oral Suspension ...